Renee D. Gala - 08 May 2025 Form 4/A - Amendment Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Renee D. Gala
Issuer symbol
DXCM
Transactions as of
08 May 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Jul 2025, 16:15:09 UTC
Date Of Original Report
12 May 2025
Previous filing
10 Mar 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GALA RENEE D Director 6340 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Renee D. Gala 07 Jul 2025 0001607737

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +1,161 +20% $0.000000 6,881 08 May 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on May 12, 2025, is being amended by this Form 4 to correct a calculation error that misreported the number of unvested restricted stock units granted to the reporting person on May 8, 2025. This amendment correctly reports the number of unvested restricted stock units granted to the reporting person on May 8, 2025.
F2 Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.
F3 Included in this number are 6,881 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 1,161 of which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.